qPCR Instruments Market Size, Share & Trends Analysis Report By Instrument (GeneXpert, BioFireFilmArray Systems, BMS Mic System), By Region (North America, Europe, APAC, LATAM, MEA), And Segment Forecasts, 2021 - 2028

Report Overview

The global qPCR instruments market size to be valued at USD 1.39 billion by 2028 and is expected to grow at a compound annual growth rate (CAGR) of 3.4% during the forecast period. The growing prevalence of diseases, technological advancements, and increasing demand for qPCR instruments are anticipated to drive the market over the forecast period. Increased focus on diagnostics attributed to the spread of COVID-19 is projected to propel the demand for qPCR instruments in the upcoming years. The demand for qPCR equipment and consumables is being driven by the SARS-CoV-2 pandemic. The spike in the incidence of COVID-19 is expected to add significantly to the number of preventive screenings. This can be attributed to the fact that the number of COVID-19 patients cannot be ascertained without proper screening owing to a large number of asymptomatic cases.

The launch of new products is expected to change certain market dynamics as it can increase the threat of internal substitution. Furthermore, increasing consumers’ preference for updated and advanced products is creating a demand for technologically advanced products, such as the Mic qPCR system with Bluetooth connectivity and multiple devices that can be connected to the computer simultaneously to run multiple sample sets.

The prevalence of chronic diseases, infectious diseases, and genetic disorders, such as Alzheimer’s, Turner syndrome, and Parkinson’s, has increased rapidly, which is expected to fuel the market growth. According to the CDC, chronic diseases such as cancer, diabetes, kidney diseases, and respiratory diseases, including asthma, are accountable for 7 in 10 deaths in the U.S. each year. Faster detection of diseases with PCR can allow for timely and appropriate treatment.

Increasing adoption of qPCR technologies is expected to propel this market growth. The adoption of qPCR techniques is increasing owing to their accuracy, automation, precise results, real-time quantification, and sensitivity. qPCR offers a wide range of input nucleic acids, making it an effective and useful technology in research applications.

qPCR Instruments Market Trends

The increased frequency of infectious diseases like malaria, HIV, and hepatitis, as well as genetic disorders like cancer and syndromes, are likely to drive the real-time PCR market forward. The usage of clinical diagnostic tests is expected to expand owing to the rising prevalence of genetic diseases worldwide and the established usefulness of qPCR analysis in the estimation and detection of disease-causing bacteria. As a result, the qPCR market is expected to grow substantially in the forecast period.

Owing to the presence of qPCR tools that are more advanced and accurate, the market faces a high risk of external alternatives. Furthermore, a usual qPCR method has a number of technical limitations, including signal measurement over the exponential phase of the PCR reaction, difficulties in target detection due to reaction inhibitors, the need for assay process optimization and validation, and the failure to detect target molecules due to low nucleotide template quality. Overall, these factors are projected to inhibit the market growth.

Among many other technological developments in the medical business, nucleic acid detection-based techniques have become speedy and reliable for viral detection. The qualitative PCR approach, which is characterized by high sensitivity, quick detection, and specificity is regarded as the "gold standard" for virus detection. In many nations, research funding is used to assist the COVID-19 treatment which is anticipated to offer lucrative opportunities for the expansion.

Instrument Insights

The GeneXpert segment accounted for the largest revenue share of over 20.0% in 2020 and is expected to witness the fastest growth over the forecast period. This is attributed to its increased adoption rate during the SARS-CoV-2 pandemic for the detection of infections. This system provides 24/7 testing accuracy, workflow flexibility, and user-friendly designs. They offer multiple tests on a single, scalable, and consolidated workstation. Key features of this system include high adjustability, touchscreen, increased accumulator capacity, expanded conveyor and loading zone, expanded test shuttle, and self-containment. It also has a faster, quieter, and more robust robotic gantry.

The BioFire FilmArray systems segment held the second-largest revenue share in 2020 owing to rapid and accurate automated detection of infections and pathogens in blood, gastrointestinal, meninges, and respiratory tract with the instrument. The instrument is available in BioFire Torch System and BioFire FilmArray 2.0 versions.

The BMS Mic system segment is anticipated to grow owing to its low weight, making it portable and easy to handle. Fast PCR results are provided by the equipment by completion of 32 PCR cycles in 25 minutes. In addition, features such as Bluetooth can enhance its connectivity to a PC or laptop. Furthermore, multiple Mic qPCR systems can be connected to one operating computer, thereby enhancing the number of samples that can be tested to get results.

Regional Insights

North America accounted for the largest revenue share of 40.82% in 2020 and is expected to maintain its lead over the forecast period. The growth of this regional market is attributed to the growing regulatory support and increasing launches of novel products. The large number of instruments installed in North America, as compared to other regions, demonstrates its high diagnostic capacity. However, it reduces the opportunity for the installation of new instruments.

Asia Pacific is expected to be the fastest-growing regional market over the forecast period. The major untapped opportunities in the form of unmet medical needs, increasing initiatives for scientific research, and positive economic growth are primary growth drivers of this market.

Furthermore, the growing number of investments and strategic initiatives by new players are accelerating the market growth in the European region. For instance, in January 2020, The Discovery Labs collaborated with Deerfield Management Company to find a gene therapy CDMO with USD 1.1. billion investments.

Key Companies & Market Share Insights

The market for qPCR instruments is competitive and the key players are constantly adopting new strategies to gain dominance in the market. Companies are developing novel instruments to capture a share of this lucrative market. For instance, in November 2020, Streck announced the launch of its novel qPCR instrument Zulu RT that can be used to perform four experiments simultaneously and independently. The greater flexibility of this instrument was expected to help capture a share in the market.

Recent Developments

• In June 2022, Bio-Rad Laboratories, Inc., an American developer, and manufacturer of specialized technology products launched the CFX Duet Real-Time PCR System. The CFX Duet Technology combines Bio-CFX Rad's Opus System's robust thermal performance and patented, precise optical shuttle system with thermal grading functionality to allow optimization in fewer runs

• In May 2022, Thermo Fisher Scientific, Inc., an American supplier of scientific instrumentation, reagents, and consumables announced the launch of the QualTrak Biopharma qPCR instrument. The new QualTrak qPCR Solutions will aid in the rapid creation of new biologics to fulfill the growing demand. It consists of a premium selection of trusted Applied Biosystems solutions that allow them to save time and money by avoiding repeating and revalidating steps

• In May 2022, Roche, a Swiss multinational healthcare company, operating globally under Pharmaceuticals and Diagnostics division has created three unique LightMix Modular Virus kits in response to current monkeypox viral concerns. Multiple monkeypox viral clusters have been detected lately in several European nations and North America, which are not typical monkeypox hotspots

Real-time PCR has various significant external substitutes, including advanced instruments like dPCR and newly developed nanoplasmonic PCR. Key players are making use of their existing consumer pool in the region to provide additional products and generate more business. This strategy is useful for brands that have already built trust in the market. Some prominent players in the global qPCR instruments market include:

• Thermo Fisher Scientific, Inc.

• F. Hoffmann-La Roche Ltd.

• Bio-Rad Laboratories, Inc.

• Danaher Corporation

• Qiagen

• Agilent Technologies, Inc.

• Abbott

• bioMérieux SA

• Quantabio

• Azure Biosystems, Inc.

• Bio Molecular Systems

qPCR Instruments Market Report Scope

Global qPCR Instruments Market Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2017 to 2028. For the purpose of this study, Grand View Research has segmented the global qPCR instruments market report on the basis of instrument and region:

• Instrument Outlook (Revenue, USD Million, 2017 - 2028)

  • 7500

  • QuantStudioDx Real-Time PCR System

  • QuantStudio 5 Real-Time PCR System

  • ViiA 7 Dx

  • StepOne/ StepOne Plus

  • LightCycler 2.0/ 96/ 480/ 1536

  • Cobas 4800

  • CFX96

  • SmartCycler

  • GeneXpert

  • Rotor-Gene Q 5Plex HRM System

  • Rotor-Gene Q

  • BioFireFilmArray Systems

  • BMS Mic System

• Regional Outlook (Revenue, USD Million, 2017 - 2028)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

  • Latin America

    • Brazil

    • Mexico

  • Middle East & Africa

    • South Africa

    • UAE